Comera Life Sciences Holdings Inc
OTC:CMRA

Watchlist Manager
Comera Life Sciences Holdings Inc Logo
Comera Life Sciences Holdings Inc
OTC:CMRA
Watchlist
Price: 0.0222 USD 0.45%
Market Cap: $31

Operating Margin

-914.3%
Current
Improving
by 502.8%
vs 3-y average of -1 417.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-914.3%
=
Operating Income
$-9.1m
/
Revenue
$1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-914.3%
=
Operating Income
$-9.1m
/
Revenue
$1m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Comera Life Sciences Holdings Inc
OTC:CMRA
31 USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.1B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
167.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Lower than 93% of companies in the United States of America
Percentile
7th
Based on 14 112 companies
7th percentile
-914.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Comera Life Sciences Holdings Inc
Glance View

Market Cap
31 USD
Industry
Biotechnology

Comera Life Sciences Holdings, Inc. engages in developing medicines. The company is headquartered in Woburn, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2020-12-15. The firm applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The firm is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. Its product programs include CLS-001, a preclinical stage bio better for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage bio better for various oncology indications. The company also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.

CMRA Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-914.3%
=
Operating Income
$-9.1m
/
Revenue
$1m
What is Comera Life Sciences Holdings Inc's current Operating Margin?

The current Operating Margin for Comera Life Sciences Holdings Inc is -914.3%, which is above its 3-year median of -1 417.1%.

How has Operating Margin changed over time?

Over the last 2 years, Comera Life Sciences Holdings Inc’s Operating Margin has increased from -1 731% to -914.3%. During this period, it reached a low of -2 157.2% on Jun 30, 2022 and a high of -866.7% on Jun 30, 2023.

Back to Top